Addus Homecare (NASDAQ:ADUS) announced its earnings results on Wednesday. The company reported $0.32 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.26 by $0.06, Analyst RN reports. The company had revenue of $69.90 million for the quarter, compared to the consensus estimate of $68.07 million. During the same quarter in the prior year, the company posted $0.30 earnings per share. The company’s quarterly revenue was up 9.6% on a year-over-year basis. Addus Homecare Corporation (NASDAQ:ADUS) stock opened at $28.64 in last trading session, and closed at $23.22, trading in the range of $23.20 – $28.64. The stock showed a negative weekly performance of -18.50%.
The Rosen Law Firm announces that it is investigating potential securities fraud claims against CytRx Corporation (NASDAQ: CYTR) resulting from allegations that CytRx may have paid outsiders to inflate its stock price by publishing misleading articles while CytRx sold $86 million in new equity to investors. CytRx Corporation (NASDAQ:CYTR) shares closed at $4.17 on last trade day, by losing -12.76%. Stock 52 week range is $1.95 – $8.35. Company’s market capitalization is $231.70 million.
The Providence Service Corp. (NASDAQ:PRSC) was downgraded by analysts at EVA Dimensions from a “buy” rating to an “overweight” rating in a research report issued to clients and investors on Thursday, AnalystRatings.NET reports. The Providence Service Corporation (NASDAQ:PRSC) stock decreased -11.95% and finished the last session at $25.12. The EPS of the stock remained 1.39. Company’s market capitalization is $339.23 million.
Discovery Laboratories, Inc. (NASDAQ:DSCO) said that its fourth-quarter net loss widened to $11.7 million from $6.8 million in the prior year quarter. But, loss per share was $0.16, unchanged from last year. Included in the net loss is the change in fair value of certain common stock warrants that are classified as derivative liabilities, resulting in non-cash expense of $0.9 million and non-cash income of $5.6 million for the quarters ended December 31, 2013 and 2012, respectively. Discovery Laboratories, Inc. (NASDAQ:DSCO) stock opened at $2.47 in last trading session and closed at $2.31. The 52 week range of the stock is $1.50 – $3.05 and the day range was $2.27 – $2.51.